EUVIMEDEUVIMED entdecken
Crossref

Scaffold-leaping optimization of naphthoquinone derivatives as ferroptosis inducer against non-small lung cancer

Hua Yang, Xiaoya Wu, Mengyu Li, Yinuo Wang, Mingmei Guo, Liping Chen, Ruili Ma, Moran Sun

Bioorganic & Medicinal Chemistry Letters · 2025

DOI: 10.1016/j.bmcl.2025.130360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2025. Verfasst von Hua Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Pingyuan Laboratory, Zhengzhou University, Zhengzhou, Henan 450001, China. Hauptthemen laut MEDLINE: Ferroptosis, Naphthoquinones, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, an iron-dependent programmed cell death pathway, has emerged as a promising therapeutic target for cancer. Herein, a series of naphthoquinone derivatives were designed via scaffold-leaping optimization from lead compound QD394, synthesized and assessed for their anti-proliferation activity against five cancer cell lines, and the structure-activity relationship (SAR) were described. Of these compounds, I-21 was identified as most active, demonstrating significant anticancer efficacy in vitro (IC50 = 0.76 μM against A549 cell lines). This cytotoxic effect can be counteracted by ferrostatin-1, a ferroptosis inhibitor, indicating that I-21 may acts as a ferroptosis inducer. Mechanistic studies revealed that I-21 triggered ferroptosis by depleting glutathione (GSH), elevating reactive oxygen species (ROS) and malondialdehyde (MDA), and downregulating glutathione peroxidase 4(GPX4) expression in A549 cell lines. Furthermore, I-21 arrested the cell cycle at the G2/M phase and inhibited the migration of A549 cell lines. This study provided the first evidence of naphthoquinone derivatives as ferroptosis inducers, offering a novel leading compound for the non-small cell lung cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNaphthoquinonesAntineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorMolecular StructureCell ProliferationDose-Response Relationship, DrugReactive Oxygen SpeciesCell Line, TumorA549 Cells

Stichwörter der Autor:innen

FerroptosisNaphthoquinoneNon-small lung cancerinducer

Substanzen

NaphthoquinonesAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • School of Pharmaceutical Science and Pingyuan Laboratory, Zhengzhou University, Zhengzhou, Henan 450001, China.
  • School of Pharmaceutical Science and Pingyuan Laboratory, Zhengzhou University, Zhengzhou, Henan 450001, China. Electronic address: sunmr@zzu.edu.cn.

Förderung

  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Yang, H., Wu, X., Li, M., Wang, Y., Guo, M., Chen, L., Ma, R., & Sun, M. (2025). Scaffold-leaping optimization of naphthoquinone derivatives as ferroptosis inducer against non-small lung cancer. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2025.130360

Vancouver

Yang H, Wu X, Li M, Wang Y, Guo M, Chen L, et al. Scaffold-leaping optimization of naphthoquinone derivatives as ferroptosis inducer against non-small lung cancer. Bioorganic & Medicinal Chemistry Letters. 2025. doi:10.1016/j.bmcl.2025.130360

BibTeX
@article{Yang2025,
  author = {Yang, Hua and Wu, Xiaoya and Li, Mengyu and Wang, Yinuo and Guo, Mingmei and Chen, Liping and Ma, Ruili and Sun, Moran},
  title = {Scaffold-leaping optimization of naphthoquinone derivatives as ferroptosis inducer against non-small lung cancer},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2025},
  doi = {10.1016/j.bmcl.2025.130360}
}
Kostenlos starten →